These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6301141)

  • 1. Immunogenicity of equine herpesvirus type 1 (EHV1) and equine rhinovirus type 1 (ERhV1) following inactivation by betapropiolactone (BPL) and ultraviolet (UV) light.
    Campbell TM; Studdert MJ; Blackney MH
    Vet Microbiol; 1982 Dec; 7(6):535-44. PubMed ID: 6301141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic relationships between equine herpesvirus type 1 (equine abortion virus) and type 4 (equine rhinopneumonitis virus).
    Fitzpatrick DR; Studdert MJ
    Am J Vet Res; 1984 Oct; 45(10):1947-52. PubMed ID: 6208822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of an inactivated vaccine for equine herpesvirus type 1 in a novel hamster model.
    Skinner GR; Davies J
    Intervirology; 2000; 43(1):27-35. PubMed ID: 10773735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunokinetics of equine herpesvirus 1 in donkey mares: suppression of secondary cell-mediated response.
    Singh M; Charan S
    Rev Sci Tech; 1992 Sep; 11(3):901-8. PubMed ID: 1335311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A type-specific serological test to distinguish antibodies to equine herpesviruses 4 and 1.
    Crabb BS; MacPherson CM; Reubel GH; Browning GF; Studdert MJ; Drummer HE
    Arch Virol; 1995; 140(2):245-58. PubMed ID: 7710353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and antibody responses to equine herpesviruses 1 and 4.
    Studdert MJ
    J Am Vet Med Assoc; 1995 Sep; 207(6):698-701. PubMed ID: 7657564
    [No Abstract]   [Full Text] [Related]  

  • 7. Equine rhinopneumonitis vaccine: immunogenicity and safety in adult horses, including pregnant mares.
    Purdy CW; Ford SJ; Porter RC
    Am J Vet Res; 1978 Mar; 39(3):377-83. PubMed ID: 205144
    [No Abstract]   [Full Text] [Related]  

  • 8. Humoral and cell-mediated immune response of foals vaccinated with attenuated equine herpesvirus type 1 (EHV-1).
    Frymus T
    Zentralbl Veterinarmed B; 1980; 27(9-10):742-58. PubMed ID: 7223181
    [No Abstract]   [Full Text] [Related]  

  • 9. Equid herpesvirus 1 (EHV1) infection of equine mesenchymal stem cells induces a pUL56-dependent downregulation of select cell surface markers.
    Claessen C; Favoreel H; Ma G; Osterrieder N; De Schauwer C; Piepers S; Van de Walle GR
    Vet Microbiol; 2015 Mar; 176(1-2):32-9. PubMed ID: 25582614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular and antibody responses to equine herpesviruses 1 and 4 following vaccination of horses with modified-live and inactivated viruses.
    Ellis JA; Bogdan JR; Kanara EW; Morley PS; Haines DM
    J Am Vet Med Assoc; 1995 Mar; 206(6):823-32. PubMed ID: 7538990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of monoclonal antibodies against an attenuated vaccine strain of equine herpesvirus type 1 (EHV-1).
    Meyer H; Hübert PH
    Vet Microbiol; 1988 Sep; 18(1):95-101. PubMed ID: 2847404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Equine rhinopneumonitis vaccine: immunogenicity and safety in foals.
    Purdy CW; Porter RC; Ford SJ
    Am J Vet Res; 1978 May; 39(5):745-52. PubMed ID: 215062
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of noncytopathic equine rhinovirus 1 as a cause of acute febrile respiratory disease in horses.
    Li F; Drummer HE; Ficorilli N; Studdert MJ; Crabb BS
    J Clin Microbiol; 1997 Apr; 35(4):937-43. PubMed ID: 9157156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epitopes of glycoprotein G of equine herpesviruses 4 and 1 located near the C termini elicit type-specific antibody responses in the natural host.
    Crabb BS; Studdert MJ
    J Virol; 1993 Oct; 67(10):6332-8. PubMed ID: 7690425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccines for EHV1.
    Baker GJ
    Vet Rec; 1983 Jan; 112(5):110-1. PubMed ID: 6298987
    [No Abstract]   [Full Text] [Related]  

  • 16. Intramuscular Immunization of Mice with the Live-Attenuated Herpes Simplex Virus 1 Vaccine Strain VC2 Expressing Equine Herpesvirus 1 (EHV-1) Glycoprotein D Generates Anti-EHV-1 Immune Responses in Mice.
    Liu SA; Stanfield BA; Chouljenko VN; Naidu S; Langohr I; Del Piero F; Ferracone J; Roy AA; Kousoulas KG
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28404844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of antibodies to equine viruses in the Netherlands.
    de Boer GF; Osterhaus AD; van Oirschot JT; Wemmenhove R
    Tijdschr Diergeneeskd; 1979 Apr; 104(8):suppl 65-74. PubMed ID: 219560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vaccination against the paralytic form of EHV1?].
    Breukink HJ; Binkhorst GJ; van Oirschot JT
    Tijdschr Diergeneeskd; 1983 May; 108(9):359. PubMed ID: 6306862
    [No Abstract]   [Full Text] [Related]  

  • 19. [EHV1, to vaccinate or not?].
    Binkhorst GJ; van Oirschot JT; Breukink HJ
    Tijdschr Diergeneeskd; 1985 Mar; 110(5):189-90. PubMed ID: 2984805
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of age and pregnancy on the antibody and cell-mediated immune responses of horses to equine herpesvirus 1.
    Gerber JD; Marron AE; Bass EP; Beckenhauer WH
    Can J Comp Med; 1977 Oct; 41(4):471-8. PubMed ID: 200320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.